Lupus & Connective Tissue Diseases
From the Journals
Cocaine damage can be misdiagnosed as nasal vasculitis
In additional to similar nasal symptoms, cocaine can trigger production of antibodies that mimic the clinical presentation of granulomatosis with...
From the Journals
Antiphospholipid antibodies linked to future CV events
The study raises the possibility of one day treating the immune system in some individuals for the prevention and treatment of cardiovascular...
Conference Coverage
Childhood lupus severity linked to social determinants of health
Social determinants of health were linked to lupus disease severity in children, but it will take more than awareness among doctors to address the...
Feature
New coalition aims to revolutionize stalled lupus research
Public-private consortium plans to develop new approaches to clinical studies.
Feature
Biosimilars and patients: Discussions should address safety, cost, and anxiety about change
Physicians can respond to pushback from patients on switching to a biosimilar by offering resources and discussing options for both biosimilar and...
Latest News
Anifrolumab shows promise in refractory discoid lupus erythematosus
Anifrolumab improved symptoms and activity of DLE within 2 months in a study of eight women.
From the Journals
CT results in myositis inform cancer screening strategies
Patients with the autoantibody anti–TIF1-gamma had the highest diagnostic yield, while patients under 40 years old had a high frequency of false...
Latest News
Novel therapy shows promise for treating skin-predominant dermatomyositis
The study drug “is a potent, selective humanized IgG1-neutralizing antibody directed at IFN-beta,” said Dr. Aaron Mangold, the principal...
Feature
Experts share early details prescribing avacopan for ANCA-associated vasculitis
Rheumatologists said more data are needed to determine optimal glucocorticoid tapering and treatment duration of avacopan for patients with ANCA-...
Conference Coverage
‘Unheard of’ PAH improvement with novel drug: STELLAR
Sotatercept, a designer molecule that removes a key driver of pulmonary arterial hypertension, had efficacy and safety in the first of three...
Feature
Experts share real-world experience prescribing voclosporin, belimumab for lupus nephritis
While some rheumatologists expressed a treatment preference, patients with lupus nephritis tend to do well on both medications; however, cost and...